37 results
8-K
EX-10.2
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
above as to whether or not it agrees to accept such retention. If the Placement Agent should decline such retention, the Company shall have no further … to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement Agent hereunder, all
424B3
867h0n5ysb kx
4 Apr 23
Prospectus supplement
4:57pm
POS AM
49p61
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
PRE 14A
955vroc
21 Apr 22
Preliminary proxy
4:33pm
S-3
EX-4.2
aqrowc8cb4
7 Feb 22
Shelf registration
12:00am